An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial
- Supplementary File 1:
PDF-Document (PDF, 872 KiB)
Stenvang, J.; Budinská, E.; van Cutsem, E.; Bosman, F.; Popovici, V.; Brünner, N. An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial. Cancers 2020, 12, 977. https://doi.org/10.3390/cancers12040977
Stenvang J, Budinská E, van Cutsem E, Bosman F, Popovici V, Brünner N. An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial. Cancers. 2020; 12(4):977. https://doi.org/10.3390/cancers12040977
Chicago/Turabian StyleStenvang, Jan; Budinská, Eva; van Cutsem, Eric; Bosman, Fred; Popovici, Vlad; Brünner, Nils. 2020. "An Explorative Analysis of ABCG2/TOP-1 mRNA Expression as a Biomarker Test for FOLFIRI Treatment in Stage III Colon Cancer Patients: Results from Retrospective Analyses of the PETACC-3 Trial" Cancers 12, no. 4: 977. https://doi.org/10.3390/cancers12040977